Skip to main content

STATE STREET CORP

Position in GALT — Galectin Therapeutics Inc

CIK 93751 BOSTON, MA

Position in GALT

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$721,025
-$286,660 QoQ
Shares Held
258,432
+6.7% QoQ
Ownership
0.392%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 65% Shared 0% None 35%

Common Shares in GALT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

STATE STREET CORP holds $30,288,856,014 across 423 Biotechnology names. GALT ranks #283 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GALT

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $721,025 258,432
2025-12-31 $1,007,685 242,232
2025-09-30 $976,641 230,340
2025-06-30 $423,983 200,940
2025-03-31 $341,983 280,314
2024-12-31 $370,893 287,514
2024-09-30 $690,288 251,014
2024-06-30 $518,929 229,615
2024-03-31 $385,841 161,440
2023-12-31 $267,990 161,440
2023-09-30 $309,964 161,440
2023-06-30 $232,473 161,440
2023-03-31 $364,854 173,740
2022-12-31 $196,326 173,740
2022-09-30 $283,196 173,740
2022-06-30 $227,599 173,740
2022-03-31 $279,721 173,740
2021-12-31 $328,631 158,759
2021-09-30 $615,984 158,759
2021-06-30 $508,028 158,759
2021-03-31 $1,334,536 614,994
2020-12-31 $1,503,922 671,394
2020-09-30 $1,863,961 698,113
2020-06-30 $2,105,533 688,083
2020-03-31 $1,301,014 663,783